BRTX — BioRestorative Therapies, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1505497 ·
Last close
$0.25
Market Cap
$6.36M
52W High
$0.33
52W Low
$0.16
ADV30
1,971,135
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 23,170 | 15,785 | -3,385,733 | -2,154,405 | 4,640,279 | 3,112,679 | 1,614,637 |
| Dec 2025 | 19,600 | 17,964 | -3,825,300 | -3,207,636 | 4,079,635 | 1,511,188 | 3,722,891 |
| Sep 2025 | 11,800 | 1,230 | -3,709,011 | -3,038,277 | 5,642,662 | 602,444 | 3,435,683 |
| Jun 2025 | 303,300 | 294,571 | -3,305,287 | -2,656,263 | 8,516,559 | 1,555,251 | 3,671,235 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,788,963
Investing CF
$8,897,470
Financing CF
$2,854,791
CapEx
$-186,962
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.40
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-169,920,690
Inventory
—
Receivables
$15,500
ST Investments
$1,441,734
EBIT TTM
$-15,647,132
Pretax Income TTM
$-14,241,975
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$359,700
EBITDA
$-15,437,147
Free Cash Flow
$-6,200,023
Enterprise Value
$2,000,246
Total Cash
$2,952,922
Total Debt
$42,282
Shares Out
25,478,170
Trailing EPS
$-1.06
Book Value
$0.04
ROE
-320.5%
ROA
-119.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 359,700 | -15,647,132 | -14,241,975 | 4,079,635 | 3,722,891 | — | -10,788,963 |
| Dec 2024 | 401,000 | -11,555,194 | -8,979,381 | 12,279,799 | 3,748,406 | — | -8,230,346 |
| Dec 2023 | 145,800 | -15,137,441 | -10,417,704 | 12,611,720 | 2,607,345 | — | -6,430,211 |
| Dec 2022 | 119,800 | -18,863,507 | -13,222,296 | 16,434,691 | 6,144,352 | — | -5,913,100 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.52
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ADVB | Advanced Biomed Inc. | $6.51M | $3.98 | — |
| HLYK | HealthLynked Corp | $6.91M | $2.35 | — |
| ACON | Aclarion, Inc. | $7.78M | $3.16 | — |
| LUDG | LUDWIG ENTERPRISES, INC. | $5.04M | $0.03 | — |
| BGLC | BioNexus Gene Lab Corp | $5.00M | $2.07 | — |
News headlines (Yahoo Finance, 1h cache)
Sector Update: Healthcare Stocks Decline Tuesday Afternoon
2026-05-26 17:50 · Yahoo
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
2026-05-26 15:00 · Yahoo
What Makes Biorestorative Therapies (BRTX) a New Buy Stock
2026-05-15 16:00 · Yahoo
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 23:40 · Yahoo
BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
2026-05-13 15:00 · Yahoo
Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates
2026-05-11 22:05 · Yahoo
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
2026-05-07 21:55 · Yahoo
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
2026-05-07 16:00 · Yahoo
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
2026-05-06 12:25 · Yahoo
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
2026-04-30 14:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.